非肌层浸润性膀胱癌当代治疗模式:BCG短缺时代根治性膀胱切除术使用是否变化?
该研究利用SEER数据库分析2008至2015年诊断为高级别T1非肌层浸润性膀胱癌患者的治疗趋势,共纳入21,817例。
要点
- BCG短缺期T1HG膀胱癌的RC率显著低于短缺前(5.1% vs 5.9%)。
- 研究期间RC使用率整体显著下降(每季度OR 0.99)。
- 绝大多数T1HG患者(94.5%)接受局部治疗而非RC。
核心结论
- 在T1HG膀胱癌队列中,研究期间根治性膀胱切除术的使用显著下降,BCG短缺期RC率反而低于短缺前。
研究设计与样本
- 基于SEER数据库的回顾性队列研究,纳入2008至2015年诊断为高级别T1非肌层浸润性膀胱癌患者21,817例。
主要发现
- 94.5%的患者接受局部治疗(经尿道切除和膀胱内治疗)。
临床怎么用
- 临床中应关注BCG短缺对T1HG膀胱癌治疗路径的影响,RC使用下降的趋势需结合肿瘤学结局进一步评估。
局限性
- 研究为回顾性数据库分析,可能存在未测量的混杂因素;BCG短缺定义基于时间划分,未直接评估BCG实际可获得性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To examine recent treatment trends for non-muscle-invasive bladder cancer (NMIBC), and specifically, to assess whether there was a change in use radical cystectomy (RC) between 2008 and 2015 using data from the Surveillance, Epidemiology, and End Results database. METHODS: We identified patients presenting with high-grade T1 (T1HG) NMIBC at diagnosis during the study period. Treatment was dichotomized into "RC" and "local treatment" (which included transurethral resection and intravesical therapies). We then employed multivariable logistic regression models to assess the odds of undergoing RC across the study period. Additionally we examined the rates of RC for T1HG NMIBC during the period of BCG-shortage, defined as 2012-2015. RESULTS: We identified 21,817 individuals diagnosed with T1HG bladder cancer during the study period. The majority of patients underwent local treatment (94.5%). During the shortage period, the rate of RC for T1HG NMIBC was significantly lower compared to the preshortage era (5.1% vs 5.9%, P = .007). Across the study period, the utilization of RC for T1HG NMIBC decreased significantly (odds ratio 0.99 per quarter, 95% confidence interval 0.98-0.99, P = .017). CONCLUSION: In our cohort of patients diagnosed with T1HG bladder cancer, we found a significant decrease in the use of radical cystectomy across the study period. Contrary to the hypothesis of increasing rates of RC in the face of BCG shortage, the rate of RC was significantly higher in the pre-shortage era. Further examination of NMIBC treatment patterns will be necessary to assess the impact of BCG availability on therapeutic pathways and oncologic outcomes in patients with high-grade NMIBC.
引用
- Tully KH, Cole AP, Krimphove MJ, et al. Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era? Urology. 2020. PMID: 32805294. doi:10.1016/j.urology.2020.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。